tradingkey.logo

ReShape Lifesciences Inc

RSLS
View Detailed Chart

3.920USD

0.000
Close 09/19, 16:00ETQuotes delayed by 15 min
10.29MMarket Cap
LossP/E TTM

ReShape Lifesciences Inc

3.920

0.000
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

0.00%

1 Month

0.00%

6 Months

-75.11%

Year to Date

-96.48%

1 Year

-97.83%

View Detailed Chart

TradingKey Stock Score

No scoring data

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Ticker SymbolRSLS
CompanyReShape Lifesciences Inc
CEOMr. Paul F. Hickey
Websitehttps://www.reshapelifesciences.com/obalon/
KeyAI